Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig
Open Access
- 1 October 1982
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 46 (4) , 662-667
- https://doi.org/10.1038/bjc.1982.251
Abstract
ICRF-187 was tested for cardioprotective activity in doxorubicin-treated mice and guinea pigs. Pretreatment with i.p. ICRF-187 caused a significant decrease in the indicence of i.v. doxorubicin-induced myocardial histological damage in the mouse. I.p. ICRF-187 did not, however, reduce the effect of i.p. doxorubicin on a functional myocardial effect of this antitumour drug, a reduced histamine responsiveness of right atria in vitro. These data suggest that ICRF-187 may not be specific for all the cardiac effects of doxorubicin.Keywords
This publication has 6 references indexed in Scilit:
- REDUCTION OF CHRONIC DAUNORUBICIN CARDIOTOXICITY BY ICRF-187 IN RABBITS1981
- REDUCTION OF CHRONIC DOXORUBICIN CARDIOTOXICITY IN DOGS BY PRETREATMENT WITH (+/-)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187)1981
- The interval-force relationship: a technique for evaluating the cardiac toxicity of anthracycline analogs.1979
- Nuclear and mitochondrial effects of adriamycin in singly isolated pulsating myocardial cellsJournal of Molecular and Cellular Cardiology, 1979
- QUANTITATIVE EXPERIMENTAL EVALUATION OF ADRIAMYCIN CARDIOTOXICITY IN THE MOUSE1979
- Influence of adriamycin on calcium exchangeability in cardiac muscle and its modification by ouabainBiochemical Pharmacology, 1978